Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Highlights of the XXIII World Congress on Parkinson's Disease and Related Disorders.

Moro E, Fernandez HH.

Parkinsonism Relat Disord. 2019 Feb;59:1. doi: 10.1016/j.parkreldis.2019.03.011. No abstract available.

PMID:
31029231
2.

Chapter 33: the history of movement disorders.

Lanska DJ.

Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7. Review.

PMID:
19892136
3.

FINGERPRINT PATTERNS IN HUNTINGTON'S CHOREA AND PARKINSON'S DISEASE.

BARBEAU A, TRUDEAU JG, COITEUX C.

Can Med Assoc J. 1965 Mar 6;92:514-6.

4.

Clozapine therapy for Parkinson's disease and other movement disorders.

Pfeiffer C, Wagner ML.

Am J Hosp Pharm. 1994 Dec 15;51(24):3047-53. Review.

PMID:
7856623
5.

Movement disorders in the psychiatric patient.

Moros DA, Yahr MD.

Hosp Community Psychiatry. 1984 Apr;35(4):377-83. Review.

PMID:
6232196
6.

A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-dopa-induced chorea.

Walters AS, McHale D, Sage JI, Hening WA, Bergen M.

Clin Neuropharmacol. 1990 Jun;13(3):236-40.

PMID:
2141544
7.

The endocrinology of extrapyramidal system disorders.

Kirkpatrick B, Tamminga CA.

Neurol Clin. 1988 Feb;6(1):159-72. Review.

PMID:
2967909
8.
9.

The endocrinology of extrapyramidal system disorders.

Kirkpatrick B, Tamminga CA.

Endocrinol Metab Clin North Am. 1988 Mar;17(1):159-72. Review.

PMID:
2967753
11.

A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease.

Jahanshahi M, Brown RG, Marsden CD.

J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1169-77.

12.

Differential diagnosis of tardive dyskinesia: an overview.

Granacher RP Jr.

Am J Psychiatry. 1981 Oct;138(10):1288-97.

PMID:
6457534
13.

Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics.

Davies KM, Mercer JF, Chen N, Double KL.

Clin Sci (Lond). 2016 Apr;130(8):565-74. doi: 10.1042/CS20150153. Review.

PMID:
26957644
14.

Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.

Pham DQ, Plakogiannis R.

Ann Pharmacother. 2005 Dec;39(12):2065-72. Epub 2005 Nov 15. Review.

PMID:
16288072
15.

Neuropsychiatry of Huntington's disease and other basal ganglia disorders.

Rosenblatt A, Leroi I.

Psychosomatics. 2000 Jan-Feb;41(1):24-30. Review.

PMID:
10665265
16.

The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.

Huot P, Lévesque M, Parent A.

Brain. 2007 Jan;130(Pt 1):222-32. Epub 2006 Dec 2.

PMID:
17142832
17.

Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.

Cisbani G, Maxan A, Kordower JH, Planel E, Freeman TB, Cicchetti F.

Brain. 2017 Nov 1;140(11):2982-2992. doi: 10.1093/brain/awx255.

18.

Proprioceptive sensory function in Parkinson's disease and Huntington's disease: evidence from proprioception-related EEG potentials.

Seiss E, Praamstra P, Hesse CW, Rickards H.

Exp Brain Res. 2003 Feb;148(3):308-19. Epub 2002 Nov 30.

PMID:
12541142
19.

The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases.

Dusek P, Roos PM, Litwin T, Schneider SA, Flaten TP, Aaseth J.

J Trace Elem Med Biol. 2015;31:193-203. doi: 10.1016/j.jtemb.2014.05.007. Epub 2014 Jun 2. Review.

PMID:
24954801
20.

Inhibitory control during smooth pursuit in Parkinson's disease and Huntington's disease.

Henderson T, Georgiou-Karistianis N, White O, Millist L, Williams DR, Churchyard A, Fielding J.

Mov Disord. 2011 Aug 15;26(10):1893-9. doi: 10.1002/mds.23757. Epub 2011 May 31.

PMID:
21630355

Supplemental Content

Support Center